News for 'SARS CoV'

'Delta Plus' now variant of concern; 22 cases found: Govt

'Delta Plus' now variant of concern; 22 cases found: Govt

Rediff.com22 Jun 2021

22 cases of the Delta Plus variant of the coronavirus have been detected in India, with 16 of them being reported from Maharashtra and the remaining from Madhya Pradesh and Kerala, the government said.

Researchers develop new N95 mask that can curb Covid spread, kill virus

Researchers develop new N95 mask that can curb Covid spread, kill virus

Rediff.com4 Jul 2022

The mask can potentially be worn longer, causing less plastic waste as it does not need to be replaced as frequently, the researchers said.

Cambridge kicks off vaccine race to fight all coronaviruses

Cambridge kicks off vaccine race to fight all coronaviruses

Rediff.com26 Aug 2020

The new vaccine candidate, DIOS-CoVax2, uses banks of genetic sequences of all known coronaviruses, including those from bats, believed to be the natural hosts of many relatives of human coronaviruses.

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

Future Covid waves unlikely to have serious impact in India: Experts

Future Covid waves unlikely to have serious impact in India: Experts

Rediff.com20 Mar 2022

The reason is that because of the hybrid immunity after three waves of natural infection and a large proportion of adults receiving both doses of COVID-19 vaccine, the susceptible pool has come down drastically, Lahariya said.

Wastewater containing coronavirus may be potential threat

Wastewater containing coronavirus may be potential threat

Rediff.com25 Aug 2020

According to the scientists, sewage leaking into natural watercourses might lead to infection with the novel coronavirus SARS-CoV-2 via airborne spray.

Second round of sero survey begins in Mumbai

Second round of sero survey begins in Mumbai

Rediff.com10 Aug 2020

The study will provide information about the spread of the infection and also throw light on herd immunity.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

Rediff.com17 Aug 2020

Nobel laureate Peter Doherty says his 'big worry' is there could be refusals for other vaccines if doubts over its safety turn out to be true.

Omicron, Delta 2 pandemics going on parallelly: Virologist

Omicron, Delta 2 pandemics going on parallelly: Virologist

Rediff.com16 Jan 2022

Omicron is a 'deviant' from the COVID-19 pandemic progression script and so it must be postulated that two pandemics are going on side by side, one by the Delta and close relatives and the other by the latest variant of concern, said noted virologist Dr T Jacob John.

India 'Stay Calm' About Kraken: Experts

India 'Stay Calm' About Kraken: Experts

Rediff.com16 Jan 2023

The Kraken COVID-19 variant accounts for almost 41 per cent of all Covid infections.

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

Covaxin, Covishield mix and match 4 times as effective: Study

Covaxin, Covishield mix and match 4 times as effective: Study

Rediff.com4 Jan 2022

The most important finding of the study was that the Spike-protein neutralising antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups, D Nageshwar Reddy, Chairman of AIG Hospitals said.

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

Maharashtra health minister hints at bringing back mask rule amid Covid spike

Maharashtra health minister hints at bringing back mask rule amid Covid spike

Rediff.com27 Apr 2022

Tope, however, stressed that there was no need to panic as the count of active cases in the state still stood below 1,000, while the number of cases per million in the state was far less than other states.

How bats offer clues to combat COVID-19

How bats offer clues to combat COVID-19

Rediff.com13 Jul 2020

While bats are the ancestral hosts to many deadly viruses affecting humans such as Ebola, rabies, and the novel coronavirus, SARS-CoV-2, the flying mammals themselves tolerate these pathogens without ill effects

Every Covid patient infecting 2 others as Delhi's R-value up to 2.1: IIT

Every Covid patient infecting 2 others as Delhi's R-value up to 2.1: IIT

Rediff.com23 Apr 2022

Delhi's R-value, which indicates the spread of COVID-19, was recorded at 2.1 this week, implying that every infected person is infecting two others in the national capital, according to an analysis by IIT-Madras.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.

India definitely not in community transmission stage: Govt

India definitely not in community transmission stage: Govt

Rediff.com11 Jun 2020

"Lockdown and containment (measures) have been successful in keeping it low and preventing rapid spread," ICMR Director General Balram Bhargava said, citing the sero-survey on COVID-19 spread.

New Covid XE variant not more severe than Omicron: Dr Kang of CMC Vellore

New Covid XE variant not more severe than Omicron: Dr Kang of CMC Vellore

Rediff.com8 Apr 2022

The World Health Organisation has issued warning against XE, a new variant of Omicron first detected in the UK.

With over 30 mutations, Omicron may evade vaccines: Dr Guleria

With over 30 mutations, Omicron may evade vaccines: Dr Guleria

Rediff.com29 Nov 2021

The presence of spike protein facilitates a virus' entry into the host cell and is responsible for making it transmissible and causing infection.

WHO doesn't recommend BCG vaccine for Covid-19

WHO doesn't recommend BCG vaccine for Covid-19

Rediff.com14 Apr 2020

In its daily situation report, the WHO said there is no evidence that the BCG vaccine protects people against COVID-19.

Spread of Delta variant will substantially up cases: WHO

Spread of Delta variant will substantially up cases: WHO

Rediff.com14 Jul 2021

As of July 13, at least 111 countries, territories and areas have reported detection of the Delta variant, and this is expected to continue to increase, becoming the dominant variant globally in the coming months.

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

Vaccines will work against new COVID-19 variant: Govt

Vaccines will work against new COVID-19 variant: Govt

Rediff.com29 Dec 2020

'Most vaccines do target the Spike protein, in which there are changes in the variants but vaccines stimulate our immune system to produce a wide range of protective antibodies'

What I learnt from fighting COVID-19

What I learnt from fighting COVID-19

Rediff.com3 Aug 2020

'Social distancing, wearing masks and hygiene should be practised more strictly.'' 'People should not assemble in close spaces as the micro droplets may hang in the air and can last for a longer time.'

Kerala institute develops kit to detect COVID-19 in 2 hrs: Vardhan

Kerala institute develops kit to detect COVID-19 in 2 hrs: Vardhan

Rediff.com18 Apr 2020

The diagnostic test kit developed by the Thiruvananthapuram institute can detect coronavirus in 10 minutes, and the sample to result time will be less than two hours, Vardhan tweeted. A total of 30 samples can be tested in a single batch on a single machine, he said.

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Rediff.com12 Nov 2021

The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.

Oxford varsity enrols volunteers for Covid vaccine trial

Oxford varsity enrols volunteers for Covid vaccine trial

Rediff.com28 Mar 2020

The researchers, working in an 'unprecedented' vaccine development effort to prevent COVID-19, said they have started screening healthy volunteers (aged 18-55) from Friday for their upcoming trial in the Thames Valley Region of England.

Centre concerned over Covid positivity rate spike amid H3N2 cases

Centre concerned over Covid positivity rate spike amid H3N2 cases

Rediff.com11 Mar 2023

The states were requested to take a stock of hospital preparedness such as availability of drugs and medical oxygen, vaccination coverage against COVID-19 and influenza.

COVID-19 vaccine unlikely before Fall of 2021: Experts

COVID-19 vaccine unlikely before Fall of 2021: Experts

Rediff.com2 Oct 2020

Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology in late June 2020. The majority of those surveyed were mostly Canadian or American academics with an average of 25 years of experience working in the field.

'UK strain behind current COVID surge in Delhi'

'UK strain behind current COVID surge in Delhi'

Rediff.com23 Apr 2021

According to the NCDC, 415 cases of the UK strain of coronavirus were found in genomes sequenced in Delhi, followed by 23 cases of the South African strain.

Antibody treatment may reduce risk in critical Covid patients: WHO

Antibody treatment may reduce risk in critical Covid patients: WHO

Rediff.com24 Sep 2021

The COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organization guidelines published in The BMJ on Friday.

Report indicates Wuhan scientists got sick with Covid before outbreak

Report indicates Wuhan scientists got sick with Covid before outbreak

Rediff.com24 May 2021

Three researchers from the Wuhan Institute of Virology sought hospital care in November 2019, weeks before Beijing disclosed the COVID-19 pandemic, a United States media report said, citing a previously undisclosed American intelligence document that could add weight to growing calls for a full scale probe of whether the coronavirus may have escaped from China's top bio lab.

British Indian doc's call for Delhi to suspend Covishield use finds support

British Indian doc's call for Delhi to suspend Covishield use finds support

Rediff.com6 Feb 2023

A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.

TN makes negative rt-pcr/vax certificate must for Kerala travellers

TN makes negative rt-pcr/vax certificate must for Kerala travellers

Rediff.com1 Aug 2021

The Tamil Nadu government on Sunday said it was mandatory for people coming from Kerala, to the state to carry a negative RT-PCR test report or vaccination certificate of two COVID doses from August 5, in the wake of a spike in infections in the neighbouring state.

With Omicron, 3rd wave projected to hit India by Feb

With Omicron, 3rd wave projected to hit India by Feb

Rediff.com6 Dec 2021

With Omicron, the new variant of SARS-CoV2, the third wave of coronavirus could hit the peak by February with cases likely to be reaching up to 1-1.5 lakh a day in the country, but it will be milder than the second wave, Manindra Agarwal, IIT scientist involved in the mathematical projection of trajectory of COVID-19, said.

India reports 6 cases of UK coronavirus strain

India reports 6 cases of UK coronavirus strain

Rediff.com29 Dec 2020

All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Rediff.com22 Mar 2022

Noting that various mathematical models meant for predicting coronavirus waves have repeatedly failed to give reliable results due to a small sample size, the Centre on Tuesday said it is closely following the virus trajectory globally, given the emergence of its new variants.

Covid 3rd wave has ended, no chance of 4th wave, unless...: Expert

Covid 3rd wave has ended, no chance of 4th wave, unless...: Expert

Rediff.com8 Mar 2022

Noting that the third wave of Covid-19 has ended in India, eminent virologist Dr T Jacob John said he is "fairly confident" that no fourth wave will occur in the country unless an unexpected variant that behaves differently comes up.